Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
0.490
+0.004 (0.89%)
At close: Nov 20, 2024, 4:00 PM
0.476
-0.014 (-2.86%)
After-hours: Nov 20, 2024, 7:27 PM EST
Spruce Biosciences Revenue
Spruce Biosciences had revenue of $602.00K in the quarter ending September 30, 2024, a decrease of -80.41%. This brings the company's revenue in the last twelve months to $7.10M, down -1.40% year-over-year. In the year 2023, Spruce Biosciences had annual revenue of $10.09M.
Revenue (ttm)
$7.10M
Revenue Growth
-1.40%
P/S Ratio
2.84
Revenue / Employee
$244,862
Employees
29
Market Cap
20.24M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
American Shared Hospital Services | 24.97M |
ProPhase Labs | 12.75M |
Palatin Technologies | 2.38M |
Pieris Pharmaceuticals | 1.35M |
iBio, Inc. | 175.00K |
SPRB News
- 10 days ago - Spruce Biosciences Reports Third Quarter 2024 Financial Results and Provides Corporate Updates - Business Wire
- 16 days ago - Spruce Biosciences, Inc. Is Being Investigated For Securities Fraud And The Schall Law Firm Urges Affected Shareholders To Reach Out - Accesswire
- 17 days ago - Investors Are Invited To Join The Schall Law Firm In An Inquiry Into Spruce Biosciences Inc For Securities Law Violations - Accesswire
- 18 days ago - Spruce Biosciences, Inc. Is Being Investigated For Securities Fraud And The Schall Law Firm Urges Affected Shareholders To Take Part - Accesswire
- 22 days ago - Investors With Losses Are Invited To Join The Schall Law Firm's Inquiry Into Spruce Biosciences Inc For Possible Securities Law Violations - Accesswire
- 23 days ago - Spruce Biosciences to Participate in the Guggenheim Securities Healthcare Innovation Conference - Business Wire
- 4 weeks ago - Spruce Biosciences, Inc. Is Being Investigated For Securities Fraud And The Schall Law Firm Urges Shareholder Participation - Accesswire
- 4 weeks ago - Spruce Biosciences, Inc. Is Being Investigated For Possible Securities Fraud And The Schall Law Firm Urges Shareholder Participation - Accesswire